In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
  • Select events

    Select Select events(s)

  • Year

    Select Year(s)

  • Resource type

    Select Resource type(s)

  • Topic

    Select Topic(s)

Filters (0)
  • Select events
  • sub-topic
  • Year
  • Resource type
  • Topic
  • Select events
  • sub-topic
  • Year
  • Resource type
  • Topic

Sponsored content

Presentations below are part of sessions sponsored by Bayer

188 results for your search

Clinical scenario 1: Anticoagulation for patients with pulmonary embolism from hospital to home: Insights from the 2019 ESC PE guideline updates and HOT-PE trial.

Event : ESC Congress 2020

  • Session : Treatment challenges in VTE: Exploring solutions with rivaroxaban across three clinical scenarios
  • Speaker : SV Konstantinides (Mainz,DE)
  • Sponsored by Bayer AG

Clinical scenario 2: Identifying patients eligible for extended VTE treatment: Insights from EINSTEIN CHOICE and EINSTEIN EXT.

Event : ESC Congress 2020

  • Session : Treatment challenges in VTE: Exploring solutions with rivaroxaban across three clinical scenarios
  • Speaker : J Weitz (Hamilton,CA)
  • Sponsored by Bayer AG

Clinical scenario 3: Interpreting the evidence base for rivaroxaban in the treatment of cancer-associated thrombosis: What does it mean for your patient?

Event : ESC Congress 2020

  • Session : Treatment challenges in VTE: Exploring solutions with rivaroxaban across three clinical scenarios
  • Speaker : A Khorana (Cleveland,US)
  • Sponsored by Bayer AG

How can we protect patients long-term after a percutaneous coronary intervention (PCI)?

Event : ESC Congress 2020

  • Session : Towards a new standard of care in coronary and peripheral artery disease: from trial results to guidelines and beyond
  • Speaker : R Welsh (Edmonton,CA)
  • Sponsored by Bayer AG

Live Questions and Answers and closing.

Event : ESC Congress 2020

  • Session : Towards a new standard of care in coronary and peripheral artery disease: from trial results to guidelines and beyond
  • Sponsored by Bayer AG

New insights from a deep dive into VICTORIA data and its potential impacts.

Event : ESC Congress 2020

  • Session : Therapeutic advances in HFrEF patients who have had a previous worsening HF event
  • Speaker : J Ezekowitz (Edmonton,CA)
  • Sponsored by Bayer AG

Optimizing protection for patients with symptomatic chronic peripheral artery disease.

Event : ESC Congress 2020

  • Session : Towards a new standard of care in coronary and peripheral artery disease: from trial results to guidelines and beyond
  • Speaker : M Brodmann (Graz,AT)
  • Sponsored by Bayer AG

Panel discussion and live Q&A.

Event : ESC Congress 2020

  • Session : Therapeutic advances in HFrEF patients who have had a previous worsening HF event
  • Speaker : CS Lam (Singapore,SG), B Pieske (Berlin,DE), J Ezekowitz (Edmonton,CA), J Butler (Atlanta,US)
  • Sponsored by Bayer AG

Patients with AF and diabetes: Is it possible to avoid irreversible complications?

Event : ESC Congress 2020

  • Session : A new decade for patients with Atrial Fibrillation: Protect the irreplaceable
  • Speaker : M Patel (Durham,US), P Rossing (Gentofte,DK), C Coleman (Suffield,US)
  • Sponsored by Bayer AG

Protecting the patient that needs more: moving from ‘stable coronary artery disease’ to ‘chronic coronary syndromes’.

Event : ESC Congress 2020

  • Session : Towards a new standard of care in coronary and peripheral artery disease: from trial results to guidelines and beyond
  • Speaker : J Steffel (Zurich,CH)
  • Sponsored by Bayer AG

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now
logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are